Biodesix Inc. (BDSX) is a diagnostic company focused on lung disease. The company develops and commercializes diagnostic tests for lung cancer and other pulmonary conditions, serving providers, payers, patients, and biopharmaceutical companies. Its products support clinical decision-making and it also provides services to biopharmaceutical companies. Biodesix operates in the U.S. and seeks reimbursement coverage from insurance payers for its diagnostic tests.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076547 | EDGAR | 95K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030835 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0000950170-24-023513 | EDGAR | — |
| 2023-03-06 | 2022-12-31 | 0000950170-23-006092 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0000950170-22-003495 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013512 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001193125-25-262532 | EDGAR | 33K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105026 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070339 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0000950170-24-119792 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092773 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055651 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060226 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039073 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021238 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021488 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014433 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0000950170-22-009126 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001193125-26-076521 | EDGAR | 3K words |
| 2025-11-03 | 0001193125-25-262508 | EDGAR | — |
| 2025-10-01 | 0001193125-25-226749 | EDGAR | — |
| 2025-09-15 | 0001193125-25-203746 | EDGAR | — |
| 2025-09-11 | 0001193125-25-200766 | EDGAR | — |
| 2025-08-07 | 0001439725-25-000003 | EDGAR | — |
| 2025-05-21 | 0001193125-25-124047 | EDGAR | — |
| 2025-05-13 | 0000950170-25-070292 | EDGAR | — |
| 2025-04-17 | 0001193125-25-084319 | EDGAR | — |
| 2025-03-28 | 0000950170-25-046748 | EDGAR | — |
99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001439725 |
| Ticker | BDSX |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report